Business
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin
BOULDER, CO / ACCESS Newswire / March 18, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented
About this update from Sonoma Pharmaceuticals, Inc.
[{"type":"text","content":"BOULDER, CO / ACCESS Newswire / March 18, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and animal health care, today announced the launch of Aquanil® AD, a hypochlorous acid based dermatology product line for sensitive skin, developed exclusively for Persōn & Covey, Inc. for distribution through its established over-the-counter dermatology channels in the United States. The Aquanil AD product line includes Aquanil AD Repair Mist, a soothing spray for irritated or damaged skin; Aquanil AD Recovery Gel, designed to help reduce the appearance of scars; and Aquanil AD Rescue Serum for relief from rashes, itching and irritation. Each product was specifically designed for sensitive or reactive skin.\"The incomparable safety profile of Sonoma's Microcyn technology made it an ideal choice for our Aquanil line and our commitment to providing relief for individuals with sensitive skin,\" remarked Marisa Brenninkmeyer, CEO of Persōn & Covey. \"We are thrilled to make hypochlorous acid-based products available to our customers, as we know the dermatological benefits of HOCl.\"\"We are excited to partner with such a highly regarded company as Persōn & Covey, whose dedication to those with sensitive skin aligns with Sonoma's mission to provide safe and effective skin care solutions,\" noted Amy Trombly, CEO of Sonoma. \"We look forward to growing this partnership and sharing our technology with more consumers across the United States.\"About Sonoma Pharmaceuticals, Inc.Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Sonoma's products are clinically proven to reduce itch, pain, scarring, and irritation safely and without damaging healthy tissue. In-vitro and clinical studies of HOCl show it to safely manage skin abrasions, lacerations, minor irritations, cuts, and intact skin. Sonoma's products are sold either directly or via partners in over 55 countries worldwide and ...